Please provide your email address to receive an email when new articles are posted on . Ulipristal acetate may be beneficial for treating premenstrual dysphoric disorder, according to results of a ...
The mental symptoms of premenstrual dysphoric disorder improve following treatment with a progesterone receptor modulator, as demonstrated by SciLifeLab researcher Erika Comasco and Professor Inger ...
Ulipristal acetate is a steroid that reversibly binds to the progesterone receptor and selectively modulates its activity. It was shown in previous studies to successfully control fibroid-related ...
Swiss specialty biopharmaceutical firm PregLem SA closed a Series B round, raising CHF36 million (US$32.2 million) to support development and regulatory activities for a late-stage selective ...
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results